USPTO 2015–2025 USPTO PatentsView US Corporation

Second Sight Medical Products, Inc.

USPTO PatentsView assignee record - 135 granted patents across 29 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Second ranks #2,851 of 49,997 tracked US assignees by granted-patent volume, with 135 patents across 29 technology areas.

#2,851
of 49,997 US assignees by volume
Top 24%
by Innovation Score (44.9/100)
12.2
avg claims per patent
-82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2851 · US Corporation #2,851 · 135 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 135 grants
  • TOP-DECILE #2,851/49,997
  • PHOTO-FINISH RH US
  • CPC-FOCUS A61N · 29 areas
  • INNOV-PAR 44.9/100
  • CLAIMS-RICH 12.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -82% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: RH US, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Second

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Second's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Second's grants concentrate

Second Sight Medical Products, Inc. is a focused PatentsView assignee: 29 CPC subclasses with 91.9% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (30 grants) versus a trough of 1 in 2024. By volume, Second sits between RH US, LLC and Bruker Nano, Inc..

Second's three-year grant acceleration

From 2019–2021 to 2022–2024, Second Sight Medical Products, Inc. moved from 25 to 6 grants (0.24x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,051. See the growth leaderboard.

Who files at Second's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Second holds 135 patents at rank #2,853, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Second

By rank, the assignees closest to #2,853 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Second's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Second, neither rank-band nor same-CPC leaders (those blocks stay above).

Second's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 24% higher than 76% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

010203040 201520162017201820192020202120222024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Second Sight Medical Products, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 30 22.2%
2016 23 17.0%
2017 24 17.8%
2018 27 20.0%
2019 10 7.4%
2020 9 6.7%
2021 6 4.4%
2022 5 3.7%
2024 1 0.7%

Which technologies does Second Sight Medical Products, Inc. patent most?

Top 15 of 29 technology areas

Where it ranks

Overall rank by patents

#2,851

of 49,997 tracked assignees

Innovation Score

44.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Second Sight Medical Products, Inc.'s patent record in context - here's where to go next.

  • Second Sight Medical Products, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 91.9% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #2,851 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Second Sight Medical Products, Inc. against RH US, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 44.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.